top of page

By ULY CLINIC

​

General treatment of leprosy 

​

Introduction

​

Leprosy is a chronic granulomatous disease caused by Mycobacterium leprae. It mainly affects the skin, the peripheral nerves and the mucous membranes. Leprosy is the commonest cause of peripheral neuritis in the world. 

 

Diagnostic Criteria 

​

  • Hypo pigmented anaesthetic macula or nodular and erythematous skin lesions

  • Nerve thickening. 

  • Burning sensations in the skin 

  • Numbness and tingling of the feet and/or hands

  • Weakness of eyelids, hands or feet

  • Painless swellings or lumps in the face and earlobes

  • Painless wounds or burns on the hands or feet 

  • Presence of any one among the three cardinal signs of leprosy below:

  • Skin patch with loss of sensation

  • One or more enlarged peripheral nerves

  • Presence of leprosy bacilli–positive smear  

​

Classification of Leprosy 

​

Multibacillary (MB) Leprosy 

​

  • Patients with six or more leprosy skin lesions 

  • Positive skin smear   

​

Paucibacillary (PB) Leprosy 

​

  • Patients with one to five leprosy skin lesions  

  • Negative skin smear  

​

Note: If there is any doubt regarding the classification, the patient should be classified and treated as a multi-bacillary case

​

Pharmacological Treatment

​

Patients should be treated by multidrug combination therapy; dosage may depend with classification and whether patient is adult or children 

​

Treatment of Leprosy 

general treatment of leprosy-ulyclinic

Treatment of leprosy in special cases

​

Tuberculosis:

 

Patients suffering from both tuberculosis and leprosy require appropriate anti-Tuberculosis therapy in addition to the MDT. A: Rifampicin must be given in the dose required for the treatment of tuberculosis. Once the intensive phase of anti TB treatment is completed, the patient should continue with his/her monthly rifampicin for leprosy treatment.   

​

There are two types of reactions

​

  • Reverse Reaction (RR) or type I reaction 

  • Erythema Nodosum Leprous (ENL) or type II reaction (For detail refer Manual for Management of Leprosy for Health Workers)   

​

Treatment of Reaction:

 

Depending on severity, treatment of RR is by giving anti- inflammatory drugs or corticosteroids usually prednisolone for a prolonged period.   

​

Note: Health care worker should communicate with DTLC when suspect leprosy reaction  

 

Updated on, 31.10.2020

​

References

​

1. STG 

bottom of page